A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
Conditions
End Stage Renal Disease (ESRD) · Kidney Failure · Chronic Renal Disease · Hemodialysis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
AKDHC Medical Research Services, LLC, Phoenix, Arizona, United States
Contact: Principal Investigator (Shouwen Wang, MD)Sarasota Memorial Hospital, Sarasota, Florida, United States
Contact: Principal Investigator (Inkyong Parrack, MD)University of South Florida, Tampa, Florida, United States
Contact: Principal Investigator (Aurelia Thibonnier, MD)Piedmont Augusta, Augusta, Georgia, United States
Contact: Principal Investigator (Houman Tamaddon, MD)University of Louisville, Louisville, Kentucky, United States
Contact: Principal Investigator (Amit Dwivedi, MD)University of Maryland, Baltimore, Maryland, United States
Contact: Principal Investigator (Khanjan Nagarsheth, MD)Brigham & Women's Hospital, Boston, Massachusetts, United States
Contact: Principal Investigator (Nicholas Swerdlow, MD)Rutgers, Newark, New Jersey, United States
Contact: Principal Investigator (Saqib Zia, MD)Mount Sinai Hospital, New York, New York, United States
Contact: Principal Investigator (Ajit Rao, MD)Northwell Health, New York, New York, United States
Contact: Principal Investigator (Kenneth Nakazawa, MD)Montefiore Medical Center, The Bronx, New York, United States
Contact: Principal Investigator (Saadat Shariff, MD)Surgical Specialists of Charlotte, Charlotte, North Carolina, United States
Contact: Principal Investigator (Jason Burgess, MD)Duke University Medical Center, Durham, North Carolina, United States
Contact: Principal Investigator (Tristen Chun, MD)NC Heart and Vascular Research, LLC, Raleigh, North Carolina, United States
WakeMed, Raleigh, North Carolina, United States
Contact: Principal Investigator (Kirk Charles, MD)Guthrie Clinic, Sayre, Pennsylvania, United States
Contact: Principal Investigator (Amber Hussain, MD)Prisma Health- Upstate, Greenville, South Carolina, United States
Contact: Study coordinator (Maggie Salle, RN- Research Coordinator) · margaret.salle@prismahealth.org · 864-607-3405Contact: Principal Investigator (Sagar Gandhi, MD)Medical University of South Carolina, Orangeburg, South Carolina, United States
Contact: Principal Investigator (Mark London, MD)John Ross, MD (Sub-investigator)Baylor Heart and Vascular, Dallas, Texas, United States
Contact: Study coordinator (Katalin Martits-Chalangari) · katalin.martitschalangari@bswhealth.org · 214-820-1722Contact: Principal Investigator (Stephen Hohmann, MD)Houston Methodist Hopsital, Houston, Texas, United States
Contact: Principal Investigator (Eric Peden, MD)University of Washington, Seattle, Washington, United States
Contact: Principal Investigator (Elina Quiroga, MD)
Study leads
John Ross, MD
Principal Investigator
MUSC Health Dialysis Access Institute